ACSTAcasti PharmaACST info
$2.39info-2.45%24h
Global rank29434
Market cap$17.77M
Change 7d-2.45%
YTD Performance-16.14%
SP500 benchmarkUnderperform
P/E-0.42
P/S0
Revenue$0
Earnings-$42.43M
Dividend yield-
Main Sector
Healthcare

Acasti Pharma (ACST) Cash on Hand

ACST Cash on Hand in 2022: $27.89M

According to Acasti Pharma latest financial reports the cash on hand of ACST is $27.89M, an decrease of -36.12% to 2022. At the end of 2022 company had $43.66M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.

ACST Cash on Hand History from 2019 to 2023

-
Value:-

ACST Cash on Hand by year

YearCash on HandChange
2023$27.89M-36.12%
2022$43.66M-28.11%
2021$60.73M326.48%
2020$14.24M-24.72%
2019$18.92M-

View the Top Cash on Hand Companies arrow right

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org